Latest News & Features
article
We hear from Oxford University Innovations and HGF about how collaboration has helped the faster development of the much needed vaccines in this past year. Hear from our panellists as they discuss the advantages of collaboration, how to pick a partner, and whether partnering up changes your normal practices. We will also hear about how to navigate the patenting of a new vaccine developed by a joint enterprise. 28 January 2021
Big Pharma
Biopharmaceutical company, Quercis Pharma, has exclusively licensed two patents to enhance its ability to provide approved treatments for COVID-19 and cancer. 28 January 2021
Americas
The US Federal Trade Commission is suing Endo Pharmaceuticals, Impax Laboratories, and Impax’s owner Amneal Pharmaceuticals, alleging that they were party to a 2017 agreement that violated antitrust law. 28 January 2021
Americas
In a win for Johnson & Johnson, its Actelion unit has settled an infringement lawsuit after generic drug maker Laurus conceded that a patent for a pulmonary hypertension drug was valid. 28 January 2021
Big Pharma
The US Court of Appeals for the Federal Circuit has dismissed an attempt by Valeant Pharmaceuticals to overturn a ruling that restricted where Hatch-Waxman Act patent lawsuits can be filed. 27 January 2021
Big Pharma
Reckitt Benckiser has dropped a $1.4bn claim against former subsidiary Indivior, which it filed following its record settlement with the US government over the marketing of an opioid treatment. 26 January 2021
Americas
In a win for medical laboratory BioTelemetry, the US Supreme Court has refused to review a court ruling that revived a cardiac monitoring patent. 26 January 2021
Americas
A US federal court has upheld a preliminary injunction against a Chinese doctor accused of stealing trade secrets from US heart device manufacturer AtriCure. 26 January 2021
Africa
Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations. 25 January 2021
Big Pharma
A subsidiary of MSD has failed to revive a record $2.5bn verdict against Gilead Sciences, after the US Supreme Court refused to hear arguments that a patent was improperly invalidated. 21 January 2021